Harokopio University
Ανάλυση γενετικού υπόβαθρου σε ασθενείς με οικογενή υπερχοληστερολαιμία. Συσχέτιση γονότυπου-φαινότυπου
Abstract
dc:descriptionFamilial hypercholesterolemia is an autosomal dominant disease with a prevalence of 1:500. The disease is mainly caused by mutations in the low density lipoprotein receptor gene (LDLR). It is characterised mainly by high serum total cholesterol levels and LDL-C above 200mg/dL. The great variability in lipid levels and the prevalence of coronary artery disease may not be solely explained by the type of LDLR mutation. Other factors such as the environment and modifying genes have been found to affect the phenotype of the disease. The aims of the study were (a) to identify mutations in LDLR gene (number, type, frequency) in familial hypercholesterolemia patients, (b) to find out their distribution in Greece, (c) to correlate the mutations with the phenotype and (d) to analyse genes involved in the development of coronary artery disease and lipid metabolism for common polymorphisms and correlate them with the phenotype. Using DGGE and DNA sequencing analysis, we found 17 mutations were found on the LDLR gene in 67 probands and 11 relatives. Mutations were located in the promoter and 8 different exons (2, 5, 6, 8, 9, 11, 12 and 14) of the LDLR. Among them 11 were missense mutations, two were nonsense mutations, 3 were splice defects (2140+5G>A and 2140+9C>T, 1706-10 G>A) and 1 one was a nucleotide substitution (-45delT) on the promoter. The mutations V408M, G528D, C6W and S265R, account for 73% of heterozygous familial hypercholesterolemia probands. V408M mutation is more common in Central West, while C6W is more common in Central East. From the above mutations A410T, A519T, and the splice site defects 2140+9 C>T are detected for the first time in the Greek population and -45delT is mentioned for the first time worldwide. Expression studies for the newly reported -45delT mutation revealed that the patient bearing the mutated allele had reduced expression to 5% of normal which resulted in reduction of LDL-R binding properties by 76%. Dividing the patients into two groups, receptor defective and receptor negative carriers it was shown that receptor negative carriers have higher total and LDL cholesterol levels, and 6-fold higher incidence of xanthomas. Apart from the genetic analysis performed in LDLR and ApoB genes, analysis in genes known to be involved in biochemical pathways implicated in the progression and the development of cardiovascular disease. The presence of the E4 allele for the ApoE genotype is not associated with lipid levels or the incidence of coronary disease in familial hypercholesterolemia. Other polymorphisms investigated are PON 2 Ser311Cys, LPL Asn291Ser, PAI-1 T11053G, FGB G-455A, NOS A-922G and ANP T2238C and G644A. The PON2 Cys311 allele was correlated with high total and LDL cholesterol and apolipoprotein B levels, while LPL Asn291, PAI-1 T11053, FGΒ G-455 and NOS A-922 allele were correlated with high apolipoprotein B levels. Only the A allele of the ANP G644A was associated with lower levels of Apo-A and HDL-C. These results suggest the Greek population is very homogenous regarding the LDLR mutations compared to others. The type of LDLR mutation affects the clinical phenotype of familial hypercholesterolemia and other genes seem to be involved in the determination of the lipid profile of patients.
Degree
thesis:*- Grantor dc:publisher
- Harokopio University
- Year dc:date
- 2006
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Choumerianou, Despoina
- Χουμεριανού, Δέσποινα
Subjects
dc:subject × 16Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/14088